Sinobioway Group

Sinobioway Group Co., Ltd. was one of the university-owned enterprises of Peking University (the other were Founder Group, Jade Bird Software and Peking University Science Park). The company currently majority (60%) owned by a Peking University professor and other employee of Peking University. The pinyin of the Chinese short name was Wèimíng Jítuán, literally Anonymous Group (or Unnamed Group). However, Sinobioway was not related to other Weiming Group, such as Weiming (Fujian) Investment Group.

Sinobioway Group
Typeprivate
IndustryBio-technology
Founded19 October 1992 (1992-10-19)
HeadquartersPKU Biological Industry Park,
Beijing
,
China
Area served
mainland China
Key people
Pan Aihua(Chairman)
Yang Xiaomin(President)
Luo Deshun(Vice-President)
Zhao Furong(Vice-President)
Wang Jun(Vice-President)
Owner
Hainan Tiandao Investment(60%)
Peking University(40%)
ParentHainan Tiandao Investment
Websitesinobioway.com
Sinobioway Group Co., Ltd.
Simplified Chinese北京北大未名生物工程集团有限公司
Traditional Chinese北京北大未名生物工程集團有限公司
Literal meaningBeijing Peking University Anonymous Bio-engineering Group Limited Company
Sinobioway Group
Simplified Chinese未名集团
Traditional Chinese未名集團
Literal meaningAnonymous Group

Sinobioway Group was incorporated on 19 October 1992. The group now involved in pharmaceutical, agriculture, environment management and other industries.

Equity investments

Sinobioway Group is the largest shareholder of Sinobioway Medicine (SZSE: 002581) for 26.38% (as at 30 June 2016).[1] Sinobioway Medicine was involved in the delisting of Sinovac Biotech. Sinobioway Medicine, full name "Shandong Sinobioway Medicine Co., Ltd." (formerly known as Wanchang Science & Technology), acquired "Sinobioway Medicine Co., Ltd." as part of a backdoor listing in 2015.[2]

Sinobioway Group also owned 60% stake of an intermediate holding company (Chinese: 深圳市北大高科技投资) which was the largest shareholder of PKU Hi-tech (SZSE: 000004, now known as CAU Technology) for 37.94% shares.[3] In 2005 the stake in the intermediate company were under auction by court ruling, in order to refurbish the debt of Sinobioway Group.[4] It was acquired by a subsidiary of China Agricultural University.[5]

Subsidiaries
As of 31 December 2015
  • Sinobioway Agriculture (92%)
  • Hunan PKU Sinobioway Bio-tech (53.57%)
  • Anhui Sinobioway Bio-economy Group (74%)
This list is incomplete; you can help by adding missing items with reliable sources.

Shareholders

Sinobioway Group is 60% owned by an intermediate holding company Hainan Tiandao Investment (Chinese: 海南天道投资)[6] that was owned 83.38% by Pan Aihua (Chinese: 潘爱华), a Peking University professor and chairman of the group; Yang Xiaomin (Chinese: 杨晓敏), the president for 8.80% stake, Luo Deshun (Chinese: 罗德顺), the vice-president (and former staff of PKU in student affairs) for 3.94% stake and Zhao Furong (Chinese: 赵芙蓉), the vice-president (and former auditor of PKU) for 3.88% stake. Another vice-president of the group, Wang Jun (Chinese: 王军), did not own any stake in the company.[7][6] However, according to the National Enterprise Credit Information Publicity System, the stake of Sinobioway Group were pledged in full or in part several times by the intermediate holding and Zhao Furong, in October 2012 (by Zhao personally), December 2014, June 2015, November 2015 and December 2016, to Chengdu Haizhen Investment (twice, Chinese: 成都海真投资), Guoyuan Trust (Chinese: 国元信托), Shenzhen Central Yunnan Commercial Factoring (Chinese: 深圳滇中商业保理) and 1314 Fund (Chinese: 北京恒宇天泽投资管理).[8]

The second largest shareholder of Sinobioway Group was the Peking University for 40% stake.

In the past Zhao Furong owned 30% personally as the joint-second largest shareholder of Sinobioway Group (behind the Peking University which owned 40%) in 2005.[4]

References
  1. "2016 Interim Report" (PDF). Sinobioway Medicine (in Chinese). Shenzhen Stock Exchange. 12 August 2016. Retrieved 6 February 2017.
  2. 关于核准淄博万昌科技股份有限公司向北京北大未名生物工程集团有限公司等发行股份购买资产的批复 (in Chinese). China Securities Regulatory Commission. 31 July 2015. Retrieved 6 February 2017.
  3. "2004 Annual Report" (PDF). PKU Hi-tech (in Chinese). Shenzhen Stock Exchange. 19 April 2005. Retrieved 6 February 2017.
  4. 股东持股变动报告书. PKU Hi-tech (in Chinese). 163.com. 14 April 2005. Retrieved 6 February 2017.
  5. "2005 Annual Report" (PDF). CAU Technology (in Chinese). Shenzhen Stock Exchange. 20 April 2006. Retrieved 6 February 2017.
  6. "2015 Annual Report" (PDF). Sinobioway Medicine (in Chinese). Shenzhen Stock Exchange. 18 April 2016. Retrieved 6 February 2017.
  7. 管理团队 [Management Team] (in Chinese). Sinobioway Group. Archived from the original on 2017-06-24. Retrieved 6 February 2017.
  8. National Enterprise Credit Information Publicity System (in Chinese)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.